Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 51 - 60 of 100+ results
Oncology
47 years of experience
Medical Oncology

Agamemnon Epenetos qualified in medicine from Glasgow University, Scotland in 1973 and subsequently specialized in Medical Oncology at St. Bartholomew's Hospital, London where he held an Honorary Consultant appointment in Medical Oncology.

He has been a practicing Oncologist and Cancer Researcher over the last 30 years. He was, until recently, a visiting Professor at Imperial College London. He has published widely on novel cancer therapies and has received much international recognition.

He is interested in giving the best possible cancer treatment combined with the best possible overall holistic care of the patient.

www.agamemnonepenetos.com 


Diseases, Medical Tests and Treatments

Clinical Trials and Cancer Research

Read more
Dr Sherif Raouf

Dr Sherif Raouf

1.25 miles

Dr Sherif Raouf

1.25 miles
Oncology
22 years of experience
Clinical Oncology

Dr Sherif Raouf is a cancer specialist (Consultant Clinical Oncologist) at St Bartholomew's Hospital. After having graduated in 1986, he completed his oncology training at Charing Cross, Mount Vernon and University College London Hospitals. Following that, he took up his current role at Queens Hospital, where since 2005 he has been the lead clinician in colorectal cancers and a key part of the GI team involved in managing up to 350 cancer patients a year.

Dr Raouf is also very experienced in the use of targeted therapies in the treatment of cancers and has pushed for the use of cutting edge technology. One such state of the art radiotherapy machine is called RapidArc (VMAT) which was potentially revolutionary many years ago as it more accurately targets the tumour, reducing the damage to surrounding tissues. Such targeted therapy has been shown to reduce side effects and improve prognoses.

On the research side, Dr Raouf is interested in cancer epidemiology and chemo-radiotherapy in cancer management. Furthermore, he is known globally for his role as a guest lecturer at many conferences worldwide. Consequently, he is currently a Fellow of the Royal College of Radiologists, a member of the European Society for Therapeutic Radiology and Oncology, The American Society of Radiation Oncology and The American Society of Clinical Oncology. Dr Raouf is hence clearly a figure at the top of his field, who is respected by all his peers.


Diseases, Medical Tests and Treatments

  • Biological Therapy
  • Cancer Prevention And Screening
  • Chemotherapy
  • Immunotherapy
  • Neoadjuvant
  • Radiotherapy
  • Targeted Chemo-Radiation Therapy
  • Stereotactic Radiosurgery
  • Adenocarcinoma
  • Bilary Cancer
  • Bowel Cancer
  • Cancer Of Unknown Primary
  • Cervical Cancer
  • Colorectal Cancer
  • Gastro-Intestinal Cancers
  • Gynaecological Cancers
  • Laryngeal Cancer
  • Liver Cancer
  • Lung Cancer
  • Nasal & Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuro-Endocrine Tumours (NETs)
  • Oesophageal Cancer
  • Oral (Mouth) Cancer
  • Ovarian Cancer
  • Palliative Care
  • Pancreatic Cancer
  • Penile Cancer
  • Prostate Cancer
  • Salivary Gland Cancer
  • Stomach Cancer
  • Throat Cancer
  • Urological Cancers
Read more
Oncology
37 years of experience

Professor Daniel Hochhauser is a specialist in the treatment of gastrointestinal cancer, conducting research which focuses on the development of novel therapeutics.

 

 

Professor Hochhauser qualified in medicine from Cambridge and the Royal Free Hospital Medical School. Following postgraduate training, he was appointed Clinical Fellow in Medical Oncology at the Institute of Molecular Medicine, Oxford where he completed a DPhil, subsequently training at Memorial Sloan Kettering Cancer Center New York before appointment as a consultant in 1996. 


Diseases, Medical Tests and Treatments
  • Home chemotherapy

 

  • Gastrointestinal cancers (chemotherapy)
  • Upper gastrointestinal cancers
  • Lower gastrointestinal cancers
Read more
Oncology
34 years of experience
Clinical Oncology

Dr Stephanie Gibbs graduated from the Royal Free Hospital Medical School in 1986. She trained in Oncology at the Middlesex Hospital, Mount Vernon Hospital, The Royal London Hospital and St Bartholomew's Hospital. She took up a consultant post at BHR Hospitals NHS Trust in 1998 & worked there for over 21 years. 

She specialises in the treatment of urological and breast cancers using radiotherapy and drug therapies including hormone teatments, chemotherapy, targeted therapies and radioisotope treatment. She is trained in the use of advanced radiotherapy techniques including IMRT, IGRT, the use of SpaceOAR Hydrogel for prostate radiotherapy and SABR.

My hobbies are keeping fit, theatre, and dance.


Diseases, Medical Tests and Treatments
  • Urological cancer
  • Breast cancer
  • Chemotherapy
  • Radiotherapy
  • Urological cancers
  • Chemotherapy
  • Radiotherapy
Read more
Dr Riyaz Shah

Dr Riyaz Shah

1.25 miles

Dr Riyaz Shah

1.25 miles
Oncology
26 years of experience
Clinical Oncology, Medical Oncology

Dr Riyaz Shah is a Consultant Medical Oncologist at The Harley Street Clinic and Maidstone and Tunbridge Wells NHS Trust. He specialises in lung and gastrointestinal cancers and malignant mesothelioma.

Dr Shah completed his medical degree at the University of London and obtained a First Class Honours Intercalated BSc in Experimental Pathology. Following this he undertook further medical training at The London Chest Hospital, Hammersmith Hospital, University College London, Guy’s Hospital and The Royal Marsden. In 1997 he became a member of the Royal College of Physicians of London. He undertook a Clinical Research Fellowship with The Imperial Cancer Research Fund to investigate abnormal genes in pancreatic cancer. This work led to him being awarded with a PhD by Imperial College London. Following this, Dr Shah trained to become a specialist in Medical Oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award. In 2006 he was appointed Consultant Medical Oncologist at the Kent Oncology Centre.

Dr. Shah is actively involved in training future medical oncologists and has an extensive role in clinical research. He has been a principal investigator on many trials at his centre and has been instrumental in the introduction of immunotherapy into routine clinical practice within Kent. He has served on the NCRI Lung Group, acted as chairman of the Kent Lung Network Lead and continues to be the lead for research at his Cancer Centre. He has been published widely and is regularly asked to speak both nationally and internationally on cancer issues.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Cancer of Unknown Primary 
  • Colorectal Cancer 
  • Gastro-intestinal Cancers 
  • Lung Cancer 
  • Thoracic Cancer
  • Acute Oncology
Read more
Oncology
17 years of experience
Medical Oncology

Dr Nikos Diamantis is a Medical Oncology Consultant at St Bartholomew's Hospital specialising in colorectal, oesphageal, gastric, pancreatic, liver and bile duct cancers, and cancers of unknown primary. He is the Barts Trust Lead for Acute Oncology and Cancer of Uknowon Primay.

Dr Diamantis underwent specialist training at the Imperial College Healthcare Hammersmith, St Mary's and Harefield Hospitals. He was awarded the Greek national Oncology fellowship scholarship and went on to conduct clinical research for 2 years at the Drug Development Unit of the Royal Marsden.

Research interests include immunotherapy for GI malignancies and first in human clinical trials. Dr Diamantis is a Principal Investigator for a number of Phase 2 and 3 trials.



.

Read more
Oncology
15 years of experience

Dr Dionysis Papadatos-Pastos is a Consultant Medical Oncologist at University College London Hospitals and Clinical Lead for Acute Oncology at Princess Alexandra Hospital, with specialist interests in the treatment of Lung Cancer and Mesothelioma.

Dr Papadatos-Pastos graduated with First Class honours in both Medicine at the University of Athens and his PhD in Medical Oncology in 2012, completing his medical oncology training at Guy’s and St Thomas’, St George’s University Hospitals and The Royal Marsden and undertaking his specialist certificate in Medical Oncology at the Institute of Cancer Research at the University of London.

Dr Papadatos-Pastos has conducted formal research into prognostic and predictive biomarkers, and the combination of immunotherapy drugs with novel compounds, participating in a number of drug trials, presenting his findings at conferences worldwide and publishing in peer-reviewed journals, including the Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer. He has also received the ASCO merit award in 2010.

 

 

 

 

 

 

 

 

 


Diseases, Medical Tests and Treatments
  • Development of novel targeted therapies for the treatment of lung cancer
  • Assessment pf combinations of immunotherapy drugs with other anti-cancer compounds
  • Lung
  • Nonsmall cell lung
  • Small cell lung cancer
  • Malignant mesothelioma
Read more
Dr Simon Hughes

Dr Simon Hughes

1.27 miles

Dr Simon Hughes

1.27 miles
Oncology
23 years of experience
Clinical Oncology

Dr Simon Hughes is Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust, and an Honorary Senior Lecturer at King’s College London School of Medical Education (GKT Medical School). He specialises in the treatment of Urological cancers: Bladder Cancer, Prostate Cancer and Radiotherapy for other Urological Cancers. Simon Hughes trained at Guy’s and St Thomas’ Hospitals Medical School, where he also gained a BSc with First Class honours (Anatomy). His specialist training in Clinical Oncology included posts at The Middlesex Hospital, University College London Hospitals, and Guy’s & St. Thomas’ Hospitals. He also spent over 2 years working in the Imaging Sciences Laboratories at Kings College London, and the Centre for Medical Image Computing at University College London developing novel radiotherapy techniques for the treatment of mobile tumours.


Simon continues to have an active role in Research and Development. He led the Clinical Oncology and Radiotherapy Research and Development Team at Guy’s and St. Thomas’ Hospitals for 5 years, and was also Radiotherapy Clinical Trials Lead for the South East London Cancer Network during this period. His research interests include tumour motion, radiotherapy dose escalation, integration of functional imaging into radiotherapy planning, and the combination of novel agents with radiotherapy. He is the UK lead for the ENZARAD Study, and is a member of several Trial Management Groups / Data Monitoring Committees. Simon’s other main interest is medical education. He is the Education and Training Lead for King’s Health Partners Comprehensive Cancer Centre; an Associate Clinical Dean at King’s College London School of Medical Education; and is the Clinical Education and Training Lead for King’s College London School of Cancer and Pharmacological Sciences. Nationally, Simon is the Treasurer for the British Uro-oncology Group; and was the co-opted oncologist for the British Association of Urological Surgeons: Oncology Section Committee from 2013-2017. He is also a past President of the Oncology Section of the Royal Society of Medicine (2011-2012), and served on council for over 10 years.


Diseases, Medical Tests and Treatments
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
Read more
Dr Amna Sheri

Dr Amna Sheri

1.27 miles

Dr Amna Sheri

1.27 miles
Oncology
16 years of experience
Medical Oncology

Dr Amna Sheri is a Consultant Medical Oncologist based in London. She manages all aspects of systemic therapy for early and advanced breast cancer including adjuvant therapy, neo-adjuvant therapy, immunotherapy, treatment of secondary breast cancer, novel biological and targeted therapies and breast cancer in young women.

Dr Sheri graduated from Imperial College London in 2004 and trained in Medical Oncology at the Royal Marsden Hospital. Following this, she was awarded an MD research degree from the Institute of Cancer Research for her work into the prediction of outcome following neo-adjvuant therapy. In 2015, she appointed as a Consultant Medical Oncologist specialising in Breast Cancer and Melanoma at the Royal Free Hospital.

Dr Sheri is actively involved in research particularly on the use of prognostic and predictive biomarkers in early breast cancer. She  has published extensively in peer-reviewed journals and presented her work at both national and international meetings.


Diseases, Medical Tests and Treatments
  • Biological Therapy
  • Chemotherapy
  • Clinical Trials
  • Hormone Therapy
  • Immunotherapy
  • Neoadjuvant
  • Targeted Therapy
  • Breast Cancer
  • Breast Cancer in Young Women
  • Pregnancy Assocaited Breast Cancer
  • Melanoma
Read more
Dr Laura Kenny

Dr Laura Kenny

1.27 miles

Dr Laura Kenny

1.27 miles
Oncology
24 years of experience

Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College  Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.

Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.

She was awarded a prestigious NIHR/MRC clinician scientist fellowship  in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents.  Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.

Dr Kenny was also appointed as Director of  Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK. 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Breast Cancer
Read more